{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:43:54Z","timestamp":1794278634879,"version":"4.9.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013058","name":"Jiangsu Provincial Key Research and Development Program","doi-asserted-by":"publisher","award":["BE2022761"],"award-info":[{"award-number":["BE2022761"]}],"id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470110"],"award-info":[{"award-number":["82470110"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900100"],"award-info":[{"award-number":["81900100"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.rmed.2025.108367","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:27:51Z","timestamp":1758587271000},"page":"108367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Drug-induced cough risk: A pharmacovigilance study of FDA adverse event reporting system database"],"prefix":"10.1016","volume":"248","author":[{"given":"Yang","family":"Rui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyuan","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beiyi","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2611-9635","authenticated-orcid":false,"given":"Zhe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.rmed.2025.108367_bib1","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1183\/09031936.00218714","article-title":"The global epidemiology of chronic cough in adults: a systematic review and meta-analysis","volume":"45","author":"Song","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.rmed.2025.108367_bib2","doi-asserted-by":"crossref","first-page":"3562570","DOI":"10.21037\/apm-20-819","article-title":"Drug-induced chronic cough and the possible mechanism of action","volume":"9","author":"Ding","year":"2020","journal-title":"Ann. Palliat. Med."},{"issue":"3","key":"10.1016\/j.rmed.2025.108367_bib3","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ijcard.2014.07.108","article-title":"The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease","volume":"176","author":"Brugts","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.rmed.2025.108367_bib4","article-title":"A real-world disproportionality analysis of sacubitril\/valsartan: data mining of the FDA adverse event reporting system","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.rmed.2025.108367_bib5","doi-asserted-by":"crossref","first-page":"796","DOI":"10.7150\/ijms.6048","article-title":"Data mining of the public version of the FDA adverse event reporting system","volume":"10","author":"Sakaeda","year":"2013","journal-title":"Int. J. Med. Sci."},{"issue":"3","key":"10.1016\/j.rmed.2025.108367_bib6","doi-asserted-by":"crossref","DOI":"10.2196\/19266","article-title":"Complementing the US food and drug administration adverse event reporting system with adverse drug reaction reporting from social media: comparative analysis","volume":"6","author":"Zhou","year":"2020","journal-title":"JMIR public health and surveillance"},{"issue":"12","key":"10.1016\/j.rmed.2025.108367_bib7","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s40264-018-0706-7","article-title":"A critical evaluation of safety signal analysis using algorithmic standardised MedDRA queries","volume":"41","author":"Tieu","year":"2018","journal-title":"Drug Saf."},{"issue":"1","key":"10.1016\/j.rmed.2025.108367_bib8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/2168479013514236","article-title":"A review of statistical methods for safety surveillance","volume":"48","author":"Huang","year":"2014","journal-title":"Therapeutic Innovation & Regulatory Science"},{"key":"10.1016\/j.rmed.2025.108367_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.58496\/MJAIH\/2023\/010","article-title":"Employing artificial intelligence methods in drug development: a new era in medicine","volume":"2023","author":"Unogwu","year":"2023","journal-title":"Mesopotamian Journal of Artificial Intelligence in Healthcare"},{"issue":"8","key":"10.1016\/j.rmed.2025.108367_bib10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/pds.1001","article-title":"The reporting odds ratio and its advantages over the proportional reporting ratio","volume":"13","author":"Rothman","year":"2004","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"6","key":"10.1016\/j.rmed.2025.108367_bib11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pds.677","article-title":"Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports","volume":"10","author":"Evans","year":"2001","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"1","key":"10.1016\/j.rmed.2025.108367_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13293-020-00308-5","article-title":"Sex differences in pharmacokinetics predict adverse drug reactions in women","volume":"11","author":"Zucker","year":"2020","journal-title":"Biol. Sex Differ."},{"issue":"1","key":"10.1016\/j.rmed.2025.108367_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10549-020-06001-w","article-title":"Cyclin-dependent kinase 4\/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment","volume":"186","author":"Raschi","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.rmed.2025.108367_bib14","article-title":"Immune checkpoint inhibitor-related pneumonitis: research advances in prediction and management","volume":"15","author":"Lin","year":"2024","journal-title":"Front. Immunol."},{"issue":"280","key":"10.1016\/j.rmed.2025.108367_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010274","article-title":"On being less tolerant: enhanced cancer immunosurveillance enabled by targeting checkpoints and agonists of T cell activation","volume":"7","author":"Lesokhin","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.rmed.2025.108367_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s40264-022-01256-2","article-title":"The food and drug administration's (FDA's) drug safety surveillance during the COVID-19 pandemic","volume":"46","author":"Diak","year":"2023","journal-title":"Drug Saf."},{"issue":"16","key":"10.1016\/j.rmed.2025.108367_bib17","doi-asserted-by":"crossref","first-page":"9306","DOI":"10.3390\/ijms23169306","article-title":"TNF-\u03b1 affects signature cytokines of Th1 and Th17 T cell subsets through differential actions on TNFR1 and TNFR2","volume":"23","author":"Pesce","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.rmed.2025.108367_bib18","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1177\/1535370220939862","article-title":"Fungal infection risks associated with the use of cytokine antagonists and immune checkpoint inhibitors","volume":"245","author":"Li","year":"2020","journal-title":"Exp. Biol. Med."},{"issue":"1","key":"10.1016\/j.rmed.2025.108367_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13075-022-02842-6","article-title":"Comparison of developing tuberculosis following tumor necrosis factor inhibition and interleukin-6 inhibition in patients with rheumatoid arthritis: a nationwide observational study in South Korea, 2013-2018","volume":"24","author":"Jung","year":"2022","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.rmed.2025.108367_bib20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.breast.2022.02.011","article-title":"Interstitial lung disease in patients treated with cyclin-dependent kinase 4\/6 inhibitors: a systematic review and meta-analysis of randomized controlled trials","volume":"62","author":"Zhang","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.rmed.2025.108367_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1247270","volume":"13","author":"Cazzaniga","year":"2023","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.rmed.2025.108367_bib22","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1183\/09031936.00146413","article-title":"Targeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunities","volume":"44","author":"Vallath","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"11","key":"10.1016\/j.rmed.2025.108367_bib23","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.3390\/jcm9113698","article-title":"Airway epithelial dysfunction in asthma: relevant to epidermal growth factor receptors and airway epithelial cells","volume":"9","author":"Inoue","year":"2020","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.rmed.2025.108367_bib24","first-page":"1","article-title":"The JAK-STAT pathway: from structural biology to cytokine engineering","volume":"9","author":"Lv","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.rmed.2025.108367_bib25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.58496\/MJAIH\/2025\/002","article-title":"A systematic review of artificial intelligence's function in the diagnosis of lung cancer (2018\u20132024)","volume":"2025","author":"Hamad","year":"2025","journal-title":"Mesopotamian Journal of Artificial Intelligence in Healthcare"},{"issue":"4","key":"10.1016\/j.rmed.2025.108367_bib26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10067-015-2861-x","article-title":"Methotrexate as combination partner of TNF inhibitors and tocilizumab. What is reasonable from an immunological viewpoint?","volume":"34","author":"Witte","year":"2015","journal-title":"Clin. Rheumatol."},{"issue":"18","key":"10.1016\/j.rmed.2025.108367_bib27","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1111\/bph.15197","article-title":"Cough as an adverse effect on inhalation pharmaceutical products","volume":"177","author":"Chang","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.rmed.2025.108367_bib28","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.pupt.2013.02.007","article-title":"Pre-clinical studies in cough research: role of transient receptor potential (TRP) channels","volume":"26","author":"Grace","year":"2013","journal-title":"Pulm. Pharmacol. Therapeut."},{"issue":"1\u20132","key":"10.1016\/j.rmed.2025.108367_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2010.03.017","article-title":"Formulation strategy and use of excipients in pulmonary drug delivery","volume":"392","author":"Pilcer","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.rmed.2025.108367_bib30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.33393\/dti.2020.2188","article-title":"Paradoxical bronchoconstriction caused by \u03b22-adrenoceptor agonists","volume":"14","author":"Ayed","year":"2020","journal-title":"Drug Target Insights"},{"issue":"12","key":"10.1016\/j.rmed.2025.108367_bib31","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/crj.13711","article-title":"Safety outcomes of salbutamol: a systematic review and meta-analysis","volume":"17","author":"Ma","year":"2023","journal-title":"The Clinical Respiratory Journal"},{"issue":"10","key":"10.1016\/j.rmed.2025.108367_bib32","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jchf.2020.06.020","article-title":"Sacubitril\/valsartan: neprilysin inhibition 5 years after PARADIGM-HF","volume":"8","author":"Docherty","year":"2020","journal-title":"JACC. Heart Failure"},{"issue":"1","key":"10.1016\/j.rmed.2025.108367_bib33","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jacbts.2022.05.010","article-title":"Neprilysin inhibitors in heart failure: the science, mechanism of action, clinical studies, and unanswered questions","volume":"8","author":"Bozkurt","year":"2023","journal-title":"JACC. Basic to Translational Science"},{"issue":"1","key":"10.1016\/j.rmed.2025.108367_bib34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12931-019-1060-8","article-title":"Bradykinin sensitizes the cough reflex via a B2 receptor dependent activation of TRPV1 and TRPA1 channels through metabolites of cyclooxygenase and 12-lipoxygenase","volume":"20","author":"Al-Shamlan","year":"2019","journal-title":"Respir. Res."},{"issue":"1","key":"10.1016\/j.rmed.2025.108367_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-96161-w","article-title":"Integrated renin angiotensin system dysregulation and immune profiles predict COVID-19 disease severity in a south african cohort","volume":"15","author":"M\u00fcller","year":"2025","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.rmed.2025.108367_bib36","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.3390\/ijms19082372","article-title":"Prostanoid EP2 receptors are up-regulated in human pulmonary arterial hypertension: a key anti-proliferative target for treprostinil in smooth muscle cells","volume":"19","author":"Patel","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.rmed.2025.108367_bib37","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1164\/rccm.200903-0388OC","article-title":"Prostaglandin E2 mediates cough via the EP3 receptor: implications for future disease therapy","volume":"180","author":"Maher","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2025.108367_bib38","doi-asserted-by":"crossref","unstructured":"Yasuma T, Fujimoto H, D'Alessandro-Gabazza C N, et al. Epoprostenol and treprostinil: differential effects on regulatory T-cell generation in patients with pulmonary arterial hypertension[J]. Am. J. Respir. Crit. Care Med., 208(11): 1248.","DOI":"10.1164\/rccm.202308-1347LE"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125004305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125004305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T10:17:59Z","timestamp":1762337879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611125004305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":38,"alternative-id":["S0954611125004305"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108367","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-induced cough risk: A pharmacovigilance study of FDA adverse event reporting system database","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108367","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108367"}}